Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on March 1, 2004

Circulation. 2004
Published online before print March 1, 2004, doi: 10.1161/01.CIR.0000118476.29352.2A
A more recent version of this article appeared on March 16, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/10/1230    most recent
01.CIR.0000118476.29352.2Av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zal, B.
Right arrow Articles by Baboonian, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zal, B.
Right arrow Articles by Baboonian, C.
Right arrowPubmed/NCBI databases
*OMIM
*Substance via MeSH
Medline Plus Health Information
*Angina
Related Collections
Right arrow Pathophysiology
Right arrow Acute coronary syndromes

Submitted on February 4, 2003
Revised on December 8, 2003
Accepted on December 10, 2003

Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes

Behnam Zal PhD, Juan Carlos Kaski MD, DSc, FRCP, Gavin Arno BSc, Julius P. Akiyu MSc, Qingbo Xu MD, PhD, Della Cole BSc, Michael Whelan PhD, Nick Russell PhD, J. Alejandro Madrigal MD, PhD, MRCPath, I. Anthony Dodi PhD, and Christina Baboonian PhD*

From Cardiological Sciences (B.Z., J.C.K., G.A., J.P.A., Q.X., D.C., C.B.) and Onyvax Ltd (M.W., N.R.), St George’s Hospital Medical School, and the Anthony Nolan Research Institute (J.A.M., I.A.D.), Royal Free and University College London, London, UK.

* To whom correspondence should be addressed. E-mail: cbabooni{at}sghms.ac.uk.

Background--CD4+CD28null T cells are present in increased numbers in the peripheral blood of patients with acute coronary syndrome (ACS) compared with patients with chronic stable angina (CSA). The triggers of activation and expansion of these cells to date remain unclear.

Methods and Results--Twenty-one patients with ACS and 12 CSA patients with angiographically confirmed coronary artery disease and 9 healthy volunteers were investigated. Peripheral blood leukocytes were stimulated with human cytomegalovirus (HCMV), Chlamydia pneumoniae, human heat-shock protein 60 (hHSP60), or oxidized LDL (ox-LDL). CD4+CD28null cells were separated by flow cytometry and assessed for antigen recognition using upregulation of interferon-{gamma} and perforin mRNA transcription as criteria for activation. CD4+CD28null cells from 12 of 21 patients with ACS reacted with hHSP60. No response was detected to HCMV, C pneumoniae, or ox-LDL. Incubation of the cells with anti-MHC class II and anti-CD4 antibodies but not anti-class I antibodies blocked antigen presentation, confirming recognition of the hHSP60 to be via the MHC class II pathway. Patients with CSA had low numbers of CD4+CD28null cells. These cells were nonreactive to any of the antigens used. Circulating CD4+CD28null cells were present in 5 of the 9 healthy controls. None reacted with hHSP60.

Conclusions--We have shown that hHSP60 is an antigen recognized by CD4+CD28null T cells of ACS patients. Endothelial cells express hHSP60 either constitutively or under stress conditions. Circulating hHSP60-specific CD4+CD28null cells may, along other inflammatory mechanisms, contribute to vascular damage in these patients.


Key words: angina • lymphocytes • antigens




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Thewissen, V. Somers, N. Hellings, J. Fraussen, J. Damoiseaux, and P. Stinissen
CD4+CD28null T Cells in Autoimmune Disease: Pathogenic Features and Decreased Susceptibility to Immunoregulation
J. Immunol., November 15, 2007; 179(10): 6514 - 6523.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Liuzzo, L. M. Biasucci, G. Trotta, S. Brugaletta, M. Pinnelli, G. Digianuario, V. Rizzello, A. G. Rebuzzi, C. Rumi, A. Maseri, et al.
Unusual CD4+CD28null T Lymphocytes and Recurrence of Acute Coronary Events
J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1450 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Zal, C. Baboonian, and J. C. Kaski
Letter to the Editor: Autoreactive CD4+CD28- T Cells and Acute Coronary Syndromes
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): E18 - E18.
[Full Text] [PDF]


Home page
CirculationHome page
V. Rizzello, G. Liuzzo, S. Brugaletta, A. Rebuzzi, L. M. Biasucci, and F. Crea
Modulation of CD4+CD28null T Lymphocytes by Tumor Necrosis Factor-{alpha} Blockade in Patients With Unstable Angina
Circulation, May 16, 2006; 113(19): 2272 - 2277.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Pryshchep, K. Sato, J. J. Goronzy, and C. M. Weyand
T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome
Circ. Res., May 12, 2006; 98(9): 1168 - 1176.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Zhang, A. Niessner, T. Nakajima, W. Ma-Krupa, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand
Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic Plaque
Circ. Res., March 3, 2006; 98(4): 524 - 531.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Brugaletta, L M Biasucci, M Pinnelli, G Biondi-Zoccai, G Di Giannuario, G Trotta, G Liuzzo, and F Crea
Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina
Heart, February 1, 2006; 92(2): 249 - 250.
[Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Sato, A. Niessner, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque
J. Exp. Med., January 23, 2006; 203(1): 239 - 250.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Q. Xiao, K. Mandal, G. Schett, M. Mayr, G. Wick, F. Oberhollenzer, J. Willeit, S. Kiechl, and Q. Xu
Association of Serum-Soluble Heat Shock Protein 60 With Carotid Atherosclerosis: Clinical Significance Determined in a Follow-Up Study
Stroke, December 1, 2005; 36(12): 2571 - 2576.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M. M. Cerinic, N. Ronda, L. J. Jara, M. Abu-Shakra, P. L. Meroni, and Y. Sherer
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Circulation, November 22, 2005; 112(21): 3337 - 3347.
[Full Text] [PDF]


Home page
LupusHome page
G Liuzzo, G Giubilato, and M Pinnelli
T cells and cytokines in atherogenesis
Lupus, September 1, 2005; 14(9): 732 - 735.
[Abstract] [PDF]


Home page
LupusHome page
K Mandal, G Foteinos, M Jahangiri, and Q Xu
Role of antiheat shock protein 60 autoantibodies in atherosclerosis
Lupus, September 1, 2005; 14(9): 742 - 746.
[Abstract] [PDF]


Home page
CirculationHome page
H. Methe, J.-O. Kim, S. Kofler, M. Weis, M. Nabauer, and J. Koglin
Expansion of Circulating Toll-Like Receptor 4-Positive Monocytes in Patients With Acute Coronary Syndrome
Circulation, May 24, 2005; 111(20): 2654 - 2661.
[Abstract] [Full Text] [PDF]